Dr. Luca Szalontay, MD
Claim this profileNYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
Expert in Brain Tumor
Expert in Cancer
20 reported clinical trials
28 drugs studied
About Luca Szalontay, MD
Education:
- Earned an MD from Columbia University Vagelos College of Physicians and Surgeons in 2017.
- Completed a Residency in Internal Medicine at NewYork-Presbyterian/Columbia University Medical Center in 2021.
- Undertook a Fellowship in Hematology and Oncology at Herbert Irving Comprehensive Cancer Center, NewYork-Presbyterian/Columbia University Medical Center, expected completion in 2024.
Experience:
- Specialized training in Internal Medicine, Hematology, and Oncology at NewYork-Presbyterian/Columbia University Medical Center.
Area of expertise
1Brain Tumor
Global LeaderH3 K27M positive
NTRK1 positive
NTRK positive
2Cancer
Global LeaderStage IV
APC negative
FBXW7 negative
Affiliated Hospitals
Clinical Trials Luca Szalontay, MD is currently running
CBL0137
for Cancer
This trial tests CBL0137, a drug that blocks signals inside cancer cells, in patients whose solid tumors, including CNS tumors or lymphoma, have returned or not responded to treatment. By interfering with the cells' internal communication, the drug aims to stop their growth and cause them to die. CBL0137, also known as Curaxin, has shown antitumor activity in multiple cancers, including glioblastoma, renal cell carcinoma, melanoma, neuroblastoma, and small cell lung cancer.
Recruiting1 award Phase 1 & 213 criteria
ONC201
for Brain Tumor
This is a randomized, double-blind, placebo-controlled, parallel-group, international, Phase 3 study in patients with newly diagnosed H3 K27M-mutant diffuse glioma to assess whether treatment with ONC201 following frontline radiotherapy will extend overall survival and progression-free survival in this population. Eligible participants will have histologically diagnosed H3 K27M-mutant diffuse glioma and have completed standard frontline radiotherapy.
Recruiting1 award Phase 3
More about Luca Szalontay, MD
Clinical Trial Related8 years of experience running clinical trials · Led 20 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Luca Szalontay, MD has experience with
- Larotrectinib
- Tipifarnib
- Selpercatinib
- ONC201
- MTX110
- Convection-Enhanced Delivery (CED)
Breakdown of trials Luca Szalontay, MD has run
Brain Tumor
Cancer
Solid Tumors
Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Luca Szalontay, MD specialize in?
Luca Szalontay, MD focuses on Brain Tumor and Cancer. In particular, much of their work with Brain Tumor has involved H3 K27M positive patients, or patients who are NTRK1 positive.
Is Luca Szalontay, MD currently recruiting for clinical trials?
Yes, Luca Szalontay, MD is currently recruiting for 4 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Luca Szalontay, MD has studied deeply?
Yes, Luca Szalontay, MD has studied treatments such as Larotrectinib, Tipifarnib, Selpercatinib.
What is the best way to schedule an appointment with Luca Szalontay, MD?
Apply for one of the trials that Luca Szalontay, MD is conducting.
What is the office address of Luca Szalontay, MD?
The office of Luca Szalontay, MD is located at: NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York 10032 United States. This is the address for their practice at the NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.